Cargando…

Organ donation after controlled circulatory death (Maastricht classification III) following the withdrawal of life-sustaining treatment in Korea: a suggested guideline

The “Act on hospice and palliative care and decisions on life-sustaining treatment for patients at the end of life” was enacted in February 2018 in Korea. Therefore, we suggest a Korean guideline for organ donation after circulatory death (DCD) category III after the withdrawal of life-sustaining tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Hoonsung, Jung, Eun-Sil, Oh, Jae-Sook, Lee, Yong-Min, Lee, Jae-Myeong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Transplantation 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235338/
https://www.ncbi.nlm.nih.gov/pubmed/35769520
http://dx.doi.org/10.4285/kjt.21.0004
_version_ 1784736294339870720
author Park, Hoonsung
Jung, Eun-Sil
Oh, Jae-Sook
Lee, Yong-Min
Lee, Jae-Myeong
author_facet Park, Hoonsung
Jung, Eun-Sil
Oh, Jae-Sook
Lee, Yong-Min
Lee, Jae-Myeong
author_sort Park, Hoonsung
collection PubMed
description The “Act on hospice and palliative care and decisions on life-sustaining treatment for patients at the end of life” was enacted in February 2018 in Korea. Therefore, we suggest a Korean guideline for organ donation after circulatory death (DCD) category III after the withdrawal of life-sustaining treatment (WLST). Implementation of WLST includes stopping ventilation, extubation, discontinuation of inotropics and vasoconstrictors, cessation of continuous renal replacement therapy, and cessation of extracorporeal membrane oxygenation. Medical staff involved in organ procurement or transplantation surgery cannot participate in the WLST process. Following cardiac arrest, 5 minutes of “no touch time” should pass, after which circulatory death can be declared. The procurement team can enter the room after the declaration of death. The final procurement decision is made after the surgeon visually checks the organ condition. DCD category III activation in Korea will help increase organ donation and reduce the demand-supply mismatch of organ transplantation.
format Online
Article
Text
id pubmed-9235338
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Korean Society for Transplantation
record_format MEDLINE/PubMed
spelling pubmed-92353382022-06-28 Organ donation after controlled circulatory death (Maastricht classification III) following the withdrawal of life-sustaining treatment in Korea: a suggested guideline Park, Hoonsung Jung, Eun-Sil Oh, Jae-Sook Lee, Yong-Min Lee, Jae-Myeong Korean J Transplant Review Article The “Act on hospice and palliative care and decisions on life-sustaining treatment for patients at the end of life” was enacted in February 2018 in Korea. Therefore, we suggest a Korean guideline for organ donation after circulatory death (DCD) category III after the withdrawal of life-sustaining treatment (WLST). Implementation of WLST includes stopping ventilation, extubation, discontinuation of inotropics and vasoconstrictors, cessation of continuous renal replacement therapy, and cessation of extracorporeal membrane oxygenation. Medical staff involved in organ procurement or transplantation surgery cannot participate in the WLST process. Following cardiac arrest, 5 minutes of “no touch time” should pass, after which circulatory death can be declared. The procurement team can enter the room after the declaration of death. The final procurement decision is made after the surgeon visually checks the organ condition. DCD category III activation in Korea will help increase organ donation and reduce the demand-supply mismatch of organ transplantation. The Korean Society for Transplantation 2021-06-30 2021-06-30 /pmc/articles/PMC9235338/ /pubmed/35769520 http://dx.doi.org/10.4285/kjt.21.0004 Text en Copyright © 2021 The Korean Society for Transplantation https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Park, Hoonsung
Jung, Eun-Sil
Oh, Jae-Sook
Lee, Yong-Min
Lee, Jae-Myeong
Organ donation after controlled circulatory death (Maastricht classification III) following the withdrawal of life-sustaining treatment in Korea: a suggested guideline
title Organ donation after controlled circulatory death (Maastricht classification III) following the withdrawal of life-sustaining treatment in Korea: a suggested guideline
title_full Organ donation after controlled circulatory death (Maastricht classification III) following the withdrawal of life-sustaining treatment in Korea: a suggested guideline
title_fullStr Organ donation after controlled circulatory death (Maastricht classification III) following the withdrawal of life-sustaining treatment in Korea: a suggested guideline
title_full_unstemmed Organ donation after controlled circulatory death (Maastricht classification III) following the withdrawal of life-sustaining treatment in Korea: a suggested guideline
title_short Organ donation after controlled circulatory death (Maastricht classification III) following the withdrawal of life-sustaining treatment in Korea: a suggested guideline
title_sort organ donation after controlled circulatory death (maastricht classification iii) following the withdrawal of life-sustaining treatment in korea: a suggested guideline
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9235338/
https://www.ncbi.nlm.nih.gov/pubmed/35769520
http://dx.doi.org/10.4285/kjt.21.0004
work_keys_str_mv AT parkhoonsung organdonationaftercontrolledcirculatorydeathmaastrichtclassificationiiifollowingthewithdrawaloflifesustainingtreatmentinkoreaasuggestedguideline
AT jungeunsil organdonationaftercontrolledcirculatorydeathmaastrichtclassificationiiifollowingthewithdrawaloflifesustainingtreatmentinkoreaasuggestedguideline
AT ohjaesook organdonationaftercontrolledcirculatorydeathmaastrichtclassificationiiifollowingthewithdrawaloflifesustainingtreatmentinkoreaasuggestedguideline
AT leeyongmin organdonationaftercontrolledcirculatorydeathmaastrichtclassificationiiifollowingthewithdrawaloflifesustainingtreatmentinkoreaasuggestedguideline
AT leejaemyeong organdonationaftercontrolledcirculatorydeathmaastrichtclassificationiiifollowingthewithdrawaloflifesustainingtreatmentinkoreaasuggestedguideline